-
Action Alerts PLUS
Get free access to Cramer's portfolio picks at Action Alerts PLUS - Try it now Free
-
RealMoney
Jim Cramer's RealMoney team of 70+ Wall Street pros will give you wealth-building strategies - Get started Free
-
RealMoney Silver
Doug Kass + our 5 Premium Services - all in one place - Get a free 14-day trial today
-
Stocks Under $10
David Peltier is ready to help you find affordable Stocks Under $10 which could lead to a big-money payoff - Get access to his portfolio FREE
-
ETF Action
Don Dion's brand new service can help investors at all levels build profitable ETF portfolios - Learn more
RYOIX - Rydex Biotechnology Inv
Rydex Biotechnology Inv TRADE NOW
NASDAQ: RYOIX
- Price: 23.94
-
Change:
-0.13 | -0.54%
- Last Update: 4:59 PM ET 11/13/09
- Day's High: 23.94
- Day's Low: 23.94
- Open: 23.94
- Previous Close: 24.07
- 52 Week Range: 17 - 26
- Expense Ratio: 1.38 %
- Net Asset: 65,830,000
- Fund Style: Health
-
Trailing Returns:
YTD 7.42% 1 Month -11.90% 1 Year 7.27% Since Inception 8.66% -
TheStreet Rating for RYOIX:
- Rydex Biotechnology Inv
- Latest Headlines for RYOIX
- RYOIX Fund Details
Partner Headlines
- Zune to launch outside US - Financial Times
- Property groups to report gains in portfolios - Financial Times
- Japan grows at fastest pace in over two years - Financial Times
- Overseas investors target UK brokers - Financial Times
- Innolux in $5bn Chi Mei merger - Financial Times
- China says Fed policy threatens global recovery - Financial Times
- Canadian protest over RBS oil sands role - Financial Times
- Carmaker JLR secures loan of 170m - Financial Times
- High-frequency firms make inroads into US futures - Financial Times
- 'Big Brother' data plan faces friction - Financial Times
- FSA given extra clout to punish City crime - Financial Times
- Enforcer gets ready for tougher FSA cases - Financial Times
- Pearl gives 2.6m in shares to chairman - Financial Times
- Hermes sends warning to VW - Financial Times
- Vattenfall prepares to name new chief - Financial Times
- Darling pressed to hold back on EU regulation - Financial Times
- Toshiba in lithium-ion push - Financial Times
- Rolls-Royce engine tops 1,000 sales - Financial Times
- Merlin hopes to conjure IPO magic - Financial Times
Brokerage Partners
Resources
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS: Now any level of investor can trade right alongside a Wall Street pro — and enjoy 24/7 access to his portfolio! Learn More
NEW! Don Dion's ETF Action: A concise two-step strategy for learning and trading in this increasingly lucrative area of investing. For all levels of investors! Learn More
RealMoney: Jim Cramer's team of 70+ investment pros offer a daily wealth of fast-breaking market news... analyses... red-hot opportunities...and wealth-building strategies. Learn More
RealMoney Silver: The genius of Doug Kass + 5 Premium Services = an unrivaled group of expert fundamental analysts, technical analysts, and Wall Street observers. Learn More
Breakout Stocks: Bryan Ashenberg combines sophisticated screening software with eagle-eye analysis to find small and mid-caps ready to break out! Learn More
We respect your privacy.
Podcasts
Connect with TheStreet